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DOI 10.1186/s12890-015-0021-3RESEARCH ARTICLE Open AccessAre allergen batch differences and the use of
double skin prick test important?
Gert F Thomsen1*, Vivi Schlünssen2,3, Lars R Skadhauge1,4, Tine Halsen Malling5, David L Sherson6,7,
Øyvind Omland5,8 and Torben Sigsgaard2Abstract
Background: Skin prick tests (SPT) are widely used both in clinical diagnostics and in research. The standardization
of allergen extracts is well documented to be crucial for the validity of SPT, whereas less emphasis has been placed
on reproducibility and the SPT procedure itself. The objectives of this study are to clarify how the double skin prick
test procedure influence the sensitivity and specificity of the test and to analyse the differences in weal size in skin
prick tests between two batches of allergen extracts from the same vendor.
Methods: The association between rhinitis and SPT was assessed among 1135 persons from a general population
sample. SPT was performed twice with 10 common aeroallergens. In a subsample of 90 persons SPT was performed
simultaneously with five of the allergens using different batches.
Results: Thirty percent had at least one positive SPT. Among asthmatics this number was 62%. Only minor
differences were seen between the sizes of two weals from the same batch. A second SPT with the same batch did
not change the association between rhinitis and sensitization. When performing SPT with two different batches
disagreement was observed in 2% (Birch) to 11% (Cat) of the subjects.
Conclusions: Performing SPT twice with the same allergen batch does not enhance the validity of the test, and
value of double testing can be questioned. Considerable differences in SPT response with different batches from
the same manufacturer were observed. Thus inter batch differences in allergen extracts might be a source of
variability.
Keywords: Skin prick test, Aeroallergens, Population based study, Validity, RhinitisBackground
Both in daily clinical diagnostics and in epidemiological
studies a valid and reproducible test for immediate type
allergy is highly desirable. Skin Prick Test (SPT) has
been widely used. The standardization of SPT allergens
has been documented to be crucial for the validity of
SPT [1-6], but there has been less emphasis on the
reliability of the tests.
The tool used to apply the allergens have some impact
on the reliability of the tests. Masse et al. compared four in-
struments in current use and showed, that the ALK lancet
had high acceptability and the lowest variability [7].* Correspondence: gert@leifi.dk
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unless otherwise stated.According to the EAACI guidelines SPT should be
performed in duplicate [8]. The value of doing this has
been disputed. In children Devenney has shown, that the
double SPT procedure only leads to differences in about
1% of the tests [9]. In a study comparing SPT allergens
from different manufacturers van Kampen reports no
significant differences in weal size between two pricks
with the same allergen from the same source, but found
large differences between allergens from different ven-
dors [10], and these results were confirmed by others
[3,6]. Less focus have been on variation between batches
from the same manufacturer. In one study with patients
referred to an allergy clinic Bjorksten showed significant
variation in SPT reactions to different batches of allergen
from the same vendor [11].
To our knowledge the variability between two batches
from the same vendor applied simultaneously in aal. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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had the opportunity to study this issue when some of
the participants in the Danish RAV study (Risk factors
for asthma in adults) [12] at the same time were enrolled
in the GA2LEN Selenium project [13]. The objectives of
the present study were to elucidate whether double SPT
procedure enhances the sensitivity and/or specificity of
the test and to analyse the differences in weal reactions
in SPT’s with two different batches of allergen extracts
from same vendor.
Methods
Study population
This study is part of the RAV study; a Western Denmark
five centre study on risk factors for asthma in adults
[12]. From the catchment area of each of the five centres
2,000 subjects aged 20–44 standardized by gender and
age were randomly selected from the Danish Civil Regis-
tration System. In 2001–2003 an extended version of the
ECRHS II screening questionnaire (www.ECRHS.org)
was sent to these 10,000 persons. 7271 responded.
Among responders a random sample of 20 percent and
a symptom group comprising all subjects who reported
currently taking any medicine for asthma, asthma attack,
or woken by an attack of shortness of breath at any time
in the past 12 months were invited to a clinical investi-
gation in 2003–2006.
The clinical investigation consisted of an interviewer-
administered questionnaire based on the ECRHS II
protocol [14], SPT, blood samples, spirometry and meas-
urement of non-specific bronchial responsiveness.
Asthma, Rhinitis and smoking status was obtained
from the interview. Current asthma was defined as an
affirmative answer to the question “Are you currently
taking any medication (including inhalators, aerosols or
tablets) for asthma?” or the combination of an affirma-
tive answer to the question “ Has your asthma ever been
confirmed by a doctor?” and at least one of the following
questions “Have you had wheezy breathing at any time
during the last 12 months?”, “Have you woken up with a
feeling of chest tightness at any time during the last
12 months?”, “Have you had breathlessness at rest in the
daytime during the last 12 months” or “Have you woken
up with an attack of breathlessness at any time during
the last 12 months?”. “Current rhinitis” was defined as
an affirmative answer to the question “Have you had
problems of sneezing, running or stuffy nose without
having a cold or flu within the last 12 months”. The sub-
ject was then asked in which months he/she had these
problems. Seasons of the allergens were defined based
on data from Danish Meteorological Institute 2003 [15].
Birch: April-May, Grass: June-July, Mugwort: July-
August, Alternaria: July-September and Cladosporium:
June-September. Seasonal rhinitis was defined whensymptoms in all the months of the given allergen season
was reported. Subjects with perennial symptoms were
not included in the seasonal rhinitis group.
Dust mites, cat, dog and horse allergen were classified
as “Perennial allergens”. Perennial rhinitis was diagnosed
if the participant mentioned symptoms in at least
8 months of the year or could not specify “symptom
months”.
Skin prick test
The participants were asked to refrain from any antihista-
minic medication 72 hours before the visit. SPT was
carried out with commercial allergens from Alk-Abelló:
Pollens: Birch, Grass (Phleum pratense) and Mugwort
(Artemissa Vulgaris). Danders: Cat, Dog and Horse.
Moulds Alternaria (Alternaria Alternata) and Cladospor-
ium (Cladosporium Herbarum). House dust mites Derma-
tophagoides Pteronyssinus (D pter) and Dermatophagoides
Farinae (D. Farinae). Positive control: Histamine 10 mg/
ml. Negative control: 50% Glycerol in aqua solution. After
disinfection with alcohol solution ALK number tape was
placed on the volar side of the forearm and droplets of
allergen extract were applied at one side of the tape in a
predefined order. For each allergen a Phazet lancet was
pricked perpendicular through the droplet. Double SPT:
With the same lancet a second prick was made at the
opposite side of the tape, using the allergen extract on the
lancet from the first prick. This procedure was chosen
above placing another drop of allergen to reduce the ne-
cessary time as well as allergen spending. After 15 minutes
positive, negative and all allergen reactions were drawn up
on the skin and transferred with transparent adhesive tape
onto a record sheet. The SPTs were carried out by either
physicians or especially trained nurses. The largest diam-
eter and the perpendicular diameter were measured by
two readers. If different, further measurements were made
until agreement between the readers was obtained.
(Largest diameter + perpendicular diameter)/2 > = 3 mm
was considered as positive reaction and the actual weal
size was recorded. If < 3 mm the result was recorded as
negative as is usual in clinical settings.
In one centre a subsample of participants were at the
same time enrolled in the GA2LEN Selenium project [13],
namely 55 subjects from the random sample of the RAV
study and 36 subjects from the RAV symptomatic sample
who also fulfilled the GA2LEN asthma control and case
criteria. Cases were subjects with a self-reported diagnosis
of asthma and either wheezing, shortness of breath or
waking at night with breathlessness in the previous
12 months. Controls were subjects with neither a diag-
nosis of asthma nor any of the three symptoms. In
these subjects SPT’s were performed simultaneously
with 10 allergens on the right forearm (The RAV
Study) and 7 allergens on left forearm (The GA2LEN
Table 1 Number of participants, demographics and
frequency of asthma and rhinitis
Random
sample
Symptom
sample
Total
Total RAV population N 708 427 1135
GA2LEN + RAV SPT N 54 36 90
RAV SPT only N 654 391 1044
Age (SD) 33.7 (7.0) 33.7 (7.1) 33.7 (7.1)
Female (%) 379 (53.5) 245 (57.4) 624 (55.0)
Asthma (%) 66 (9.3) 211 (49.4) 277 (24.4)
Rhinitis (%) 303 (42.8) 288 (67.5) 591 (52.1)
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5 allergens were in common (Birch, Grass, Cat, D Farinae
and Alternaria), but from different production batches.
The declared allergen activity (Birch, Grass, Cat, D
Farinae) or concentration (Alternaria) did not vary be-
tween batches. The GA2LEN allergens were only pricked
once. In this subgroup, the actual weal size of all skin
pricks were recorded, even when less than 3 mm. In the
analysis of the correlation between SPT with different
batches, the first of the two RAV study pricks was used.
The term disagreement between two SPT’s is used,
when one is positive and the other negative.
Statistics
Agreements in positive tests for each allergen were cal-
culated using Kappa Statistics. To compare the ability of
the tests to identify subjects with rhinitis the sensitivity
and the specificity were calculated. When choosing the
cut-off value for a test there will always be a trade-off
between sensitivity and specificity. To encompass both,
the Youden’s indexes [16] were calculated. The Pearson
correlation coefficients were calculated to describe theTable 2 Results of SPT’s in all centres
SPT Batch 1
Prick 1 Prick 2
Allergen N Pos (%) Pos (%)
Cladosporium 1021 14 (1.4) 17 (1.7)
Alternaria 1076 45 (4.2) 46 (4.3)
Mugwort 1135 70 (6.2) 70 (6.2)
Grass pollen 1135 268 (23.6) 270 (23.8)
Birch pollen 1135 171 (15.1) 164 (14.4)
D. Farinae 1135 170 (15.0) 175 (15.4)
D. Pter. 1135 208 (18.3) 206 (18.1)
Cat 1135 143 (12.6) 149 (13.1)
Dog 1135 151 (13.3) 159 (14.0)
Horse 1135 56 (4.9) 48 (4.2)
Any allergen 1135 442 (38.9) 447 (39.3)correlation between the weal sizes of the two skin pricks
in the “two batches” procedure. The difference between
intrabatch variability and interbatch variability were
tested as follow: For each participant the difference be-
tween the sizes of the two weals with same batch (Intra-
batch) as well as the difference between Prick1 batch1
and prick batch 2 (Interbatch) were calculated. The
equality of the interbatch and intrabatch differences
were tested by Student’s t-test. The differences in number
of disagreements were tested by Wilcoxon signed-rank
test. As five comparisons are performed, p < = 0.01 was
chosen for reporting significant results. All statistical ana-
lyses were conducted in Stata 10.0 IC (Stata Cooporation
Texas, USA).
Ethical considerations
The study was approved by the Medical Ethics Committee
of Ribe & Sonderjyllands County, Fyn & Vejle County,
and Nordjyllands County. All subjects signed an informed
consent form before participating in the study.
Results
1.191 subjects attended the clinical examinations.
Thirty-four subjects refused SPT and furthermore 22
subjects refused the double SPT procedure leaving 1,135
subjects eligible for analysis. Due to shortage of allergen
extracts SPT for Cladosporium was not performed in
114 subjects and for Alternaria in 59 subjects. Among
the 91 subjects who participated in both the RAV and
the GA2LEN study one subject refused SPT leaving 90
subjects eligible for analysis. Among these, 69 subjects
accepted both double SPT with the RAV allergens and
SPT with the GA2LEN allergens.
The average age of the population was 34 years, and
55% was females. In the random sample the prevalenceRandom Sample
N = 708
Symptom Sample
N = 427
Current Asthma
N =277
% pos % pos % pos
1.1 1.9 3.9
1.9 8.5 12.6
4.5 8.9 10.5
17.7 33.5 39.0
11.6 20.8 22.7
10.0 23.2 31.1
12.7 27.6 37.2
7.6 20.8 27.4
7.1 23.7 30.3
2.8 8.4 11.6
30.5 51.1 62.1
Table 3 SPT double prick using same batch of allergen
extract
All: 1135 Asthmatics: 277
Allergen Kappa Dis-agreements Kappa Dis-agreements
Cladosporium 0.90 0.3% 0.90 0.8%
Alternaria 0.83 1.4% 0.81 4.5%
Mugwort 0.87 1.4% 0.86 2.5%
Grass 0.93 2.5% 0.92 3.6%
Birch 0.91 2.2% 0.92 2.9%
D. Farinae 0.92 2.0% 0.91 4.0%
D. Pter. 0.92 2.5% 0.92 4.0%
Cat 0.94 1.3% 0.93 2.9%
Dog 0.82 4.0% 0.84 6.9%
Horse 0.90 0.8% 0.89 2.2%
Positive result in prick 1 vs prick 2.
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43%, Table 1.
The prevalence of positive SPT in the total RAV cohort
is presented in Table 2. In the random sample of the RAV
study the prevalence varied from 1% for Cladosporium to
18% for grass. The prevalence of SPT positive reaction to
at least one allergen was 31%, in asthmatics 62%. The
prevalence of SPT in the symptom sample was, as ex-
pected, increased compared to the random sample. In
the random sample the prevalence was higher among
< 25 years compared to ≥ 25 years), 39% vs. 29% (p <
0.05), whereas for the symptom sample the prevalence
was similar across age-groups, ≈ 50%.Double SPT procedure
A high degree of concordance was seen between the two
weals when SPT was carried out with the same allergen
extract. The correlation coefficients varied from 0.88 in
Alternaria and dog to 0.94 for horse and birch. The reac-
tions to Dog allergen showed the highest rate of disagree-
ments: 4%. A higher percentage disagreements was seen
in the asthma group, whereas the Kappa values were the
same, Table 3. Disagreements were seen in both directions
except for Cladosporium. In 87% of the 1,135 participants,
agreement was seen for all 10 allergens.Table 4 SPT using two different batches of allergen extracts
N = 90 SPT Batch 1 RAV SPT Batch 2 GA2LEN
Allergen Pos (%) Pos (%) Pearso
Alternaria 8 (8.9) 10 (11.1) 0.91
Grass 29 (32.2) 35 (38.9) 0.80
Birch 16 (17.8) 18 (20.0) 0.96
D. Farinae 21 (23.3) 22 (24.4) 0.94
Cat 19 (21.1) 25 (27.8) 0.89Differences between batches
For Grass and Cat allergens the SPT mean weal size was
significantly greater for the GA2LEN panel than the RAV
panel: Grass 3.1 vs. 2.1 mm and cat 2.1 vs. 1.1 mm. For
Alternaria, birch and D Farinae no significant differences
in mean weal size was seen. The Pearson correlation
coefficients between the average diameters in the two
tests varied from 0.79 for grass to 0.94 for D Farinae.
The percent disagreement in the 90 subjects varied
from 2.2 for birch to 11.1 for cat, Table 4.
Inter batch and intra batch variation
For five allergens it was possible to compare the intra- and
inter batch variation in 69 subjects. In 54 participants
(78%) agreement between batches was seen for all five
allergens. The rate of disagreement was higher and the
Kappa value lower for two different batches compared to
double SPT with the same batch. This was true for all 5
allergens. For Alternaria, Grass and Cat the between batch
differences in weal sizes were significantly larger than the
within batch differences. When comparing number of
disagreements significance was seen for Cat only Table 5.
Allergy tests and rhinitis
Sensitivity, specificity and Youdens index for any posi-
tive SPT were calculated using rhinitis as the “true diag-
nosis” (Sensitivity = 0.57, specificity = 0,76 and Youdens
index = 0.33). The same calculations were made for posi-
tive reaction to any perennial allergen with perennial
rhinitis as the “true diagnosis” (0.37, 0.74 and 0.11) and
finally for seasonal rhinitis with symptoms in the birch,
grass and mugworth pollen seasons as the “true diagno-
sis”. For the single allergens the sensitivity were lower
and the specificity higher (Table 6) Subgroup analysis on
the random group and the asthma symptom group
showed similar results (data not shown).
To analyse whether double SPT improved the diagnos-
tic capability of the test, Prick 1 pos. was compared to
(Prick 1 pos. OR Prick 2 pos.) and to (Prick 1 pos. AND
Prick 2 pos.). As expected using (1 OR 2) showed a
slightly higher sensitivity and lower specificity, while
using (1 AND 2) lead to the reverse result. The Youden’s
index’s hardly changed, Table 6. In the current asthma
group the same patterns were seen, Table 7.n ρ for wealsize Kappa for positive test Disagreements%
0.75 4.5
0.81 8.9
0.93 2.2
0.91 3.3
0.70 11.1
Table 5 Repeated SPT with different and with same batch
N = 69 Different batches Same batch
Allergen Pearson ρ for
weal size
Kappa for
positive
Dis-
agreements
Mean
difference mm
Pearson ρ for
weal size
Kappa for
positive
Dis-
agreements
Mean
difference mm
Alternaria 0.84 0.68 5.8% 0.9 0.92 0.92 1.5% 0.3*
Grass 0.79 0.76 11.6% 1.2 0.92 0.90 4.4% 0.6*
Birch 0.97 0.95 1.4% 0.4 0.94 1.00 0% 0.3
D farinae 0.94 0.90 4.3% 0.6 0.91 0.93 2.9% 0.5
Cat 0.91 0.75 10.1% 1.2 0.92 1.00 0% ¤ 0.4*
¤p < 0.01 in Wilcoxon signed-rank test *p < = 0.005 in t-test.
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to few cases.
Discussion
In this population based study we found a substantial
number of disagreements in SPT using two different
batches of the same allergen extracts from the same
vendor. Performing double SPT using the same batch of
allergen extract did not enhance the SPT validity. This was
true for both the total group and for the asthma group.
Even though rather strict criteria were used (Doctors
diagnose or current asthma medication) the prevalence
of asthma in the random sample (9.3%) was higher than
seen in population based questionnaires, around five
percent [17]. This indicates that selection bias might be
in play, when the participants choose to take part in the
clinical investigations. As intra-individual differences are
the focus in the analysis, we do not expect this selection
to bias the results.
The SPT’s were performed following international
guidelines. Standardized extracts from a well establishedTable 6 The ability of double SPT compared to single SPT to
All N = 1135 SPT result Po
Rhinitis any time during the year Any allergen positive Pr
Pr
Pr
Perennial rhinitis Any whole year allergen positive Pr
Pr
Pr
Birch season rhinitis Birch positive Pr
Pr
Pr
Grass season rhinitis Grass positive Pr
Pr
Pr
Mugworth season rhinitis Mugworth positive Pr
Pr
Prvendor were used. All the of the weal size readings were
double checked. The SPT’s were performed at five centres,
but following the same protocol. At least one researcher
from each centre participated in a common training ses-
sion supervised by an acknowledged allergologist. In the
same batch double SPT procedure, only one drop of aller-
gen extract was used for both pricks. As the differences
between weals were small and in both directions, it is not
likely, that this led to significant bias.
The number participants in the between batch part of
the study was determined by the number included in the
Ga2len study. As very little has been published on differ-
ences in prick test reaction between bathes of the same
allergen, we did not a priory have sufficient data to make
a proper power calculation.
A total of 30.5% of the randomly selected subjects had
at least one positive SPT. This is slightly less than the
33.9% reported by Linneberg in a Danish population based
study in 1998 [18]. This difference might be explained by
a different age distribution, as the subjects in Linnebergs
study were younger (15–22) and the prevalence ofidentify persons reporting rhinitis last 12 months
sitive reactions Sensitivity Specificity Youden index (SE)
ick 1 0.56 0.77 0.33 (0.03)
ick 1 or 2 0.58 0.75 0.33 (0.03)
ick 1 and 2 0.55 0.79 0.34 (0.03)
ick 1 0.37 0.74 0.11 (0.04)
ick 1 or 2 0.39 0.73 0.12 (0.04)
ick 1 and 2 0.36 0.77 0.12 (0.04)
ick 1 0.23 0.87 0.11 (0.03)
ick 1 or 2 0.24 0.86 0.11 (0.03)
ick 1 and 2 0.22 0.88 0.11 (0.03)
ick 1 0.47 0.86 0.32 (0.03)
ick 1 or 2 0.48 0.84 0.33 (0.03)
ick 1 and 2 0.45 0.86 0.32 (0.03)
ick 1 0.11 0.95 0.06 (0.02)
ick 1 or 2 0.12 0.95 0.07 (0.02)
ick 1 and 2 0.10 0.96 0.07 (0.02)
Table 7 The ability of double SPT compared to single SPT to identify persons reporting rhinitis last 12 months
Current asthma N = 277 SPT result Positive reactions Sensitivity Specificity Youden index (SE)
Rhinitis any time during the year Any allergen positive Prick 1 0.71 0.58 0.29 (0.06)
Prick 1 or 2 0.73 0.57 0.30 (0.06)
Prick 1 and 2 0.70 0.63 0.33 (0.06)
Perennial rhinitis Any whole year allergen positive Prick 1 0.60 0.50 0.09 (0.07)
Prick 1 or 2 0.61 0.47 0.09 (0.07)
Prick 1 and 2 0.58 0.52 0.10 (0.07)
Birch season rhinitis Birch positive Prick 1 0.21 0.76 0.03 (0.05)
Prick 1 or 2 0.22 0.75 0.03 (0.05)
Prick 1 and 2 0.20 0.79 0.02 (0.05)
Grass season rhinitis Grass positive Prick 1 0.53 0.73 0.25 (0.06)
Prick 1 or 2 0.50 0.73 0.26 (0.06)
Prick 1 and 2 0.50 0.73 0.23 (0.06)
Mugworth season rhinitis Mugworth positive Prick 1 0.13 0.92 0.06 (0.04)
Prick 1 or 2 0.15 0.92 0.07 (0.04)
Prick 1 and 2 0.13 0.94 0.07 (0.04)
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[17]. The very low discrepancy in the double SPT proced-
ure is in line with van Kampen’s findings in occupational
allergens [10]. The current study gives no clue which way
to interpret a double SPT with discordant results, as the
Youden indexes barely vary between the “or” and the
“and” interpretation with no clear direction. In current
recommendations double SPT is recommended, but this
is presumably based on general consideration about
precision and not based on a systematic data analysis
[19]. Furthermore, the between batch variability is con-
siderably larger than the within batch variability. Thus
nothing is gained by performing double prick tests with
the same batch.
We use rhinitis as the “true diagnosis” when evaluating
the validity of the SPTs. More often SPT is used to validate
questionnaires or interviews (e.g. Karakaya [20] and Smith
[21]). Asthma could have been used as the target, as both
interview and spirometry data were collected for all
subjects. Asthma though, is less closely related to allergy/
atopy. Even in this younger population a substantial frac-
tion of asthma cases are non-allergic. Furthermore rhinitis
symptoms are more closely related to atopy (Braun-
Fahrlander [22]) and used as a proxy for atopy in some
studies (e.g. Schlunssen [23]).
Using the reported months with rhinitis symptom as
an indicator for the causative allergen has limitations.
Except for birch pollen the seasons of the allergens are
overlapping, and other pollens may play a role eg. hazel-
nut in the spring time. The interviews were performed
all year round and many participants had difficulties
pointing out specific months with symptoms. Since the
SPT’s were performed after the interview any bias fromthese uncertainties is expected to be non-differential,
but might partly explain the low observed sensitivities.
The differences in SPT reactions between two
batches from the same vendor are less than reported by
Nielsen [6] comparing allergen extracts from different
vendors. In some allergens (e.g. birch) the number of
positive reactions did not differ much, whereas in
others (e.g. Cat) larger differences was seen. Because
the differences for nearly all allergens were seen in both
directions and varied considerably between the allergens it
is unlikely, that the differences could be explained by study
design issues.
In all allergens except D. Farinae a higher rate of discrep-
ancies and lower correlations were observed when compar-
ing two different batches than when comparing two SPT
with the same batch. This underlines the necessity to use
the same batches of prick test allergens in multicentre
studies. When SPT is repeated over a longer period it
might not be possible to use the same batches over time.
In these cases interbatch differences should be considered
a possible source of variability.
The evaluation of variation between allergen batches
was performed with only 5 allergens in just 90 subjects
and only one vendor. The results should therefore be
interpreted with some caution. The study should be
repeated with at least all allergens in the recommended
standard panel and on a larger number of subjects. It
might also be of interest to test whether similar results
are found in allergens from other manufacturers.
Conclusions
Performing SPT twice with the same allergen batch does
not enhance the validity of the test, and double testing
Thomsen et al. BMC Pulmonary Medicine  (2015) 15:33 Page 7 of 7cannot be recommended. Considerable differences in
SPT responses with different batches from the same
vendor were observed. Thus inter batch differences in
allergen extracts might be a source of variability when
SPT reactions are followed over time or compared between
centres.
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